Methods of treatment using single doses of oritavancin
US8420592B2 · kind B2 · utility
4Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2009 |
| Grant date | Apr 16, 2013 |
| Priority date | — |
| Expiry date | Aug 29, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.